|
PhiChem Corporation (300398.SZ) DCF Valuation |
Fully Editable: Tailor To Your Needs In Excel Or Sheets
Professional Design: Trusted, Industry-Standard Templates
Investor-Approved Valuation Models
MAC/PC Compatible, Fully Unlocked
No Expertise Is Needed; Easy To Follow
PhiChem Corporation (300398.SZ) Bundle
Whether you’re an investor or analyst, this (300398SZ) DCF Calculator is your essential tool for accurate valuation. Loaded with real data from PhiChem Corporation, you can adjust forecasts and observe the effects in real-time.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2020 |
AY2 2021 |
AY3 2022 |
AY4 2023 |
AY5 2024 |
FY1 2025 |
FY2 2026 |
FY3 2027 |
FY4 2028 |
FY5 2029 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1,864.0 | 2,627.1 | 2,906.8 | 2,728.7 | 2,917.5 | 3,299.6 | 3,731.6 | 4,220.3 | 4,772.9 | 5,397.9 |
| Revenue Growth, % | 0 | 40.94 | 10.65 | -6.13 | 6.92 | 13.09 | 13.09 | 13.09 | 13.09 | 13.09 |
| EBITDA | 472.3 | 680.4 | 713.7 | 388.9 | 537.3 | 715.8 | 809.5 | 915.5 | 1,035.4 | 1,170.9 |
| EBITDA, % | 25.34 | 25.9 | 24.55 | 14.25 | 18.42 | 21.69 | 21.69 | 21.69 | 21.69 | 21.69 |
| Depreciation | 112.3 | 127.0 | 152.6 | 181.4 | 187.6 | 192.6 | 217.8 | 246.3 | 278.6 | 315.1 |
| Depreciation, % | 6.02 | 4.83 | 5.25 | 6.65 | 6.43 | 5.84 | 5.84 | 5.84 | 5.84 | 5.84 |
| EBIT | 360.0 | 553.4 | 561.1 | 207.5 | 349.8 | 523.2 | 591.7 | 669.2 | 756.8 | 855.9 |
| EBIT, % | 19.32 | 21.07 | 19.3 | 7.61 | 11.99 | 15.86 | 15.86 | 15.86 | 15.86 | 15.86 |
| Total Cash | 1,507.9 | 1,215.5 | 1,413.5 | 1,323.2 | 1,219.2 | 1,755.8 | 1,985.8 | 2,245.8 | 2,539.9 | 2,872.4 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 743.1 | 989.2 | 1,135.2 | 1,226.9 | 1,224.3 | 1,342.9 | 1,518.7 | 1,717.6 | 1,942.5 | 2,196.9 |
| Account Receivables, % | 39.86 | 37.65 | 39.05 | 44.96 | 41.96 | 40.7 | 40.7 | 40.7 | 40.7 | 40.7 |
| Inventories | 508.0 | 663.1 | 740.8 | 646.6 | 664.3 | 821.2 | 928.8 | 1,050.4 | 1,187.9 | 1,343.5 |
| Inventories, % | 27.25 | 25.24 | 25.48 | 23.7 | 22.77 | 24.89 | 24.89 | 24.89 | 24.89 | 24.89 |
| Accounts Payable | 320.4 | 539.3 | 108.7 | 116.8 | 509.8 | 417.1 | 471.7 | 533.5 | 603.4 | 682.4 |
| Accounts Payable, % | 17.19 | 20.53 | 3.74 | 4.28 | 17.47 | 12.64 | 12.64 | 12.64 | 12.64 | 12.64 |
| Capital Expenditure | -263.6 | -266.0 | -198.6 | -271.2 | -237.1 | -324.4 | -366.9 | -415.0 | -469.3 | -530.8 |
| Capital Expenditure, % | -14.14 | -10.12 | -6.83 | -9.94 | -8.13 | -9.83 | -9.83 | -9.83 | -9.83 | -9.83 |
| Tax Rate, % | 19.15 | 19.15 | 19.15 | 19.15 | 19.15 | 19.15 | 19.15 | 19.15 | 19.15 | 19.15 |
| EBITAT | 301.0 | 450.1 | 494.6 | 154.2 | 282.8 | 427.1 | 483.0 | 546.3 | 617.8 | 698.7 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -781.0 | 128.8 | -205.7 | 75.0 | 611.1 | -72.9 | 105.2 | 118.9 | 134.5 | 152.1 |
| WACC, % | 4.78 | 4.77 | 4.8 | 4.74 | 4.77 | 4.77 | 4.77 | 4.77 | 4.77 | 4.77 |
| PV UFCF | ||||||||||
| SUM PV UFCF | 361.8 | |||||||||
| Long Term Growth Rate, % | 3.00 | |||||||||
| Free cash flow (T + 1) | 157 | |||||||||
| Terminal Value | 8,848 | |||||||||
| Present Terminal Value | 7,009 | |||||||||
| Enterprise Value | 7,370 | |||||||||
| Net Debt | 368 | |||||||||
| Equity Value | 7,002 | |||||||||
| Diluted Shares Outstanding, MM | 525 | |||||||||
| Equity Value Per Share | 13.35 |
What You Will Receive
- Accurate PHICHEM Financials: Access to historical and projected data for precise valuation.
- Customizable Inputs: Adjust WACC, tax rates, revenue growth, and capital investments.
- Automatic Calculations: Intrinsic value and NPV are computed in real-time.
- Scenario Analysis: Explore various scenarios to assess PhiChem's future performance.
- User-Friendly Design: Designed for professionals while remaining accessible to newcomers.
Key Features
- Comprehensive Financial Data: Access reliable pre-loaded historical data and future forecasts for PhiChem Corporation (300398SZ).
- Tailored Forecast Assumptions: Modify yellow-highlighted cells, including WACC, growth rates, and profit margins to suit your analysis.
- Real-Time Calculations: Enjoy automatic updates to DCF, Net Present Value (NPV), and cash flow assessments.
- User-Friendly Dashboard: View intuitive charts and summaries for a clear representation of your valuation outcomes.
- Designed for All Skill Levels: A straightforward, user-friendly layout perfect for investors, CFOs, and consultants alike.
How It Functions
- Step 1: Download the Excel file.
- Step 2: Examine the pre-filled PhiChem data (historical and forecasted).
- Step 3: Modify key assumptions (highlighted in yellow) based on your analysis.
- Step 4: Observe automatic recalculations for PhiChem’s intrinsic value.
- Step 5: Utilize the results for investment decisions or reporting.
Why Opt for This Calculator?
- Designed for Experts: A sophisticated tool favored by analysts, CFOs, and consultants.
- Comprehensive Data: PhiChem Corporation’s historical and projected financials preloaded for enhanced accuracy.
- Scenario Analysis: Effortlessly simulate various forecasts and assumptions.
- Clear Results: Automatically computes intrinsic value, NPV, and essential metrics.
- User-Friendly: Step-by-step guidance leads you through the entire process.
Who Should Utilize This Product?
- Finance Students: Master valuation techniques and apply them with real-world data.
- Academics: Integrate professional models into your research or teaching materials.
- Investors: Validate your assumptions and evaluate valuation scenarios for PhiChem Corporation (300398SZ).
- Analysts: Enhance your efficiency with a customizable, ready-to-use DCF model.
- Small Business Owners: Understand how major public firms like PhiChem Corporation (300398SZ) are analyzed.
Contents of the Template
- Historical Data: Provides PhiChem Corporation's (300398SZ) previous financial information and baseline forecasts.
- DCF and Levered DCF Models: Comprehensive templates for assessing the intrinsic value of PhiChem Corporation (300398SZ).
- WACC Sheet: Pre-configured calculations for the Weighted Average Cost of Capital.
- Editable Inputs: Customize essential drivers such as growth rates, EBITDA %, and CAPEX assumptions.
- Quarterly and Annual Statements: A thorough analysis of PhiChem Corporation's (300398SZ) financial performance.
- Interactive Dashboard: Dynamic visualization of valuation outcomes and projections.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.